![Jung-Chool Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jung-Chool Kim
Directeur Général chez
APROGEN BIOLOGICS INC.
Fortune : 122 796 $ au 30/06/2026
Profil
Jung-Chool Kim currently works at Aprogen Biologics, Inc., as Co-Chief Executive Officer & Director, AP Healthcare, Inc., as Chief Executive Officer & Director from 2022, N2TECH Co., Ltd., as Director & Head-Management from 2025, and E&M Revolution Co., Ltd., as Director.
Mr. Kim also formerly worked at Chunggei Pharm Co. Ltd., as Chief Executive Officer, Aprogen, Inc., as Director, Aprogen Biologics, Inc. (Korea), as Director, and Aprogen, Inc., as Director from 2017 to 2022.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
APROGEN, INC 0,32 % | 10/07/2026 | 74 895 ( 0,32 % ) | 120 853 $ | 30/06/2026 |
APROGEN BIOLOGICS 0,01 % | 01/07/2026 | 1 458 ( 0,01 % ) | 1 943 $ | 30/06/2026 |
Postes actifs de Jung-Chool Kim
| Sociétés | Poste | Début |
|---|---|---|
| APROGEN BIOLOGICS INC. | Directeur Général | 01/04/2012 |
| APTOCROM INC. | Directeur Général | 23/03/2022 |
| N2TECH CO.,LTD | Directeur/Membre du Conseil | 31/05/2025 |
E&M Revolution Co., Ltd.
 E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Jung-Chool Kim
| Sociétés | Poste | Fin |
|---|---|---|
| APROGEN MEDICINES INC. | Directeur/Membre du Conseil | 18/07/2022 |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Directeur/Membre du Conseil | - |
Aprogen Biologics, Inc. (Korea)
 Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Engages in the production of bacterial and virus vaccines | Directeur/Membre du Conseil | - |
Chunggei Pharm Co. Ltd.
 Chunggei Pharm Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medicine | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Aprogen, Inc.
 Aprogen, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines development and carbon steel distribution services | Health Technology |
Aprogen Biologics, Inc.
 Aprogen Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
AP Healthcare, Inc.
 AP Healthcare, Inc. Medical DistributorsDistribution Services Wholesales and retails drugs and publishes mobile games | Distribution Services |
Chunggei Pharm Co. Ltd.
Chunggei Pharm Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medicine | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Engages in the production of bacterial and virus vaccines | Health Technology |
N2TECH Co., Ltd.
 N2TECH Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Manufactures hardware components for semiconductor equipment | Miscellaneous |
